Business
Ventripoint Diagnostics to Exhibit at Radiological Society of North America's 105th Scientific Assembly and Annual Meeting
(via TheNewswire) Toronto, Ontario - TheNewswire - November 29, 2019 - Ven...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Diagnostics to Exhibit at Radiological Society of North America's 105th Scientific Assembly and Annual Meeting(via TheNewswire)\n \n \nToronto, Ontario - TheNewswire - November 29, 2019 - Ventripoint Diagnostics Ltd. (\"Ventripoint\" or the \"Company\") (TSXV:VPT) (OTCQB:VPTDF) is exhibiting for the first time at the Radiological Society of North America's 105th Scientific Assembly and Annual Meeting (RSNA 2019), held in Chicago's McCormick Place from December 1-6. Join us at Booth #1133.\n\n\n \nThe conference is the world's largest radiology conference with 50,000 attendees, including professionals from 136 countries around the world who attend to see the latest technologies from the 700+ vendors in attendance, attend plenary and poster sessions, and for the 400+ educational courses. \n\n\n \nThis year's conference is particularly momentous for Ventripoint given that we recently received FDA clearance for our new model, VMS+ 3.0, and we aim to showcase the new system at this one-of-a kind conference. This will be a great opportunity to introduce the system to business leaders and healthcare professionals in radiology from around the world. \n\n\n \nThe VMS+ 3.0 connects to standard echocardiography machines, the most widely used cardiac imaging technology globally. The system uses a proprietary Knowledge Based Reconstruction (KBR) technology creating 3D images of the heart and calculates volumes & ejection fraction for all 4 cardiac chambers with accuracy equivalent to MRI. The system can reduce the need for MRI in pediatrics and adults. \n\n\n \n\"We are particularly excited about the changes we have made to the latest model of the device, including an interactive and intuitive navigational guide and the innovative tracking sensor technology that has considerably improved the user experience, and most importantly has built upon our legacy to improve patient's lives by providing innovative technology.\" - Justin Leushner, Ventripoint President & CEO.\n\n\n \nAbout Ventripoint Diagnostics Ltd.\n\n\n \nVentripoint's VMS+ 3.0 connects to standard echo machines, the most widely used cardiac imaging technology globally. The system uses a proprietary Knowledge Based Reconstruction (KBR) technology to create 3D images of the heart and calculates volumes & ejection fractions with accuracy equivalent to MRI. The...